Amy S. Rosenberg

Infectious Disease

1000 10th Ave
New York, NY 10019

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Proceedings of the 15th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals.

Journal: mAbs

Published: April 04, 2025

Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.

Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.

Journal: The AAPS journal

Published: January 02, 2025

Regulatory T cell epitope content in human antibodies decreases during maturation.

Regulatory T cell epitope content in human antibodies decreases during maturation.

Journal: Frontiers in immunology

Published: November 27, 2024

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies.

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies.

Journal: mAbs

Published: March 27, 2024

Editorial: Innovative approaches to immune tolerance and regulation with gene, cellular, protein, and microbiome based therapeutics.

Editorial: Innovative approaches to immune tolerance and regulation with gene, cellular, protein, and microbiome based therapeutics.

Journal: Frontiers in immunology

Published: February 05, 2024

Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics.

Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics.

Journal: The AAPS journal

Published: December 19, 2023

Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease.

Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease.

Journal: Frontiers in immunology

Published: September 25, 2023

Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics.

Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics.

Journal: The AAPS journal

Published: June 14, 2023

Editorial: Induction of immune tolerance: addressing unmet medical need in immune mediated diseases and immune responses to biologics.

Editorial: Induction of immune tolerance: addressing unmet medical need in immune mediated diseases and immune responses to biologics.

Journal: Frontiers in immunology

Published: May 09, 2023

Successful AAV8 readministration: Suppression of capsid-specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease.

Successful AAV8 readministration: Suppression of capsid-specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease.

Journal: The journal of gene medicine

Published: October 24, 2022

In silico Immunogenicity Assessment for Sequences Containing Unnatural Amino Acids: A Method Using Existing in silico Algorithm Infrastructure and a Vision for Future Enhancements.

In silico Immunogenicity Assessment for Sequences Containing Unnatural Amino Acids: A Method Using Existing in silico Algorithm Infrastructure and a Vision for Future Enhancements.

Journal: Frontiers in drug discovery

Published: January 01, 2022

Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.

Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats.

Journal: Toxicology letters

Published: October 22, 2021

Showing 1-12 of 56

Last Updated: 09/26/2026